Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-30

Clinical Trial Update: Estrogen Replacement in Anorexia Nervosa [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating estrogen replacement in individuals with anorexia nervosa has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estrogen Replacement Therapy (estrogen replacement therapy)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Anorexia Nervosa | Phase 2 | Status: TERMINATED